Compare
NewGenIvf Group Ltd vs Cryo Cell International Inc vs Pacific Health Care Organization Inc vs Charming Medical Ltd
| Latest fiscal year | NewGenIvf Group Ltd NIVFRevenue covers only part of its income (partial revenue) | Cryo Cell International Inc CCEL | Pacific Health Care Organization Inc PFHO | Charming Medical Ltd MCTA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-11-30 | 2025-12-31 | 2026-03-31 |
| Revenue | n/a | $31.57M | $6.72M | $4.81M |
| Revenue growth (YoY) | n/a | -1.3% | +10.7% | -22.7% |
| Gross margin | n/a | 76.6% (computed) | n/a | n/a |
| Operating margin | n/a | 1.5% | 14.9% | -0.6% |
| Net margin | n/a | -7.7% | 20.7% | -0.5% |
| Net income | $9.88M | -$2.43M | $1.39M | -$22.6K |
| EPS (Diluted) | $3.04 | -$0.30 | $0.11 | $0.00 |
| Operating cash flow | -$10.93M | $5.48M | $1.16M | -$1.22M |
| Free cash flow | -$11.06M | $5.25M | $1.14M | -$1.56M |
| Cash & equivalents | $758.6K | $319.0K | $2.17M | $4.70M |
| Total assets | $32.72M | $61.73M | $13.46M | $9.87M |
| Total liabilities | $6.74M | $80.33M | n/a | $4.69M |
| Shareholders' equity | $25.99M | -$18.61M | $13.07M | $5.18M |
| Return on year-end equity | 38.0% | n/a | 10.6% | -0.4% |
| Shares outstanding | 240.6K | 8.06M | 12.80M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | NewGenIvf Group Ltd | Cryo Cell International Inc | Pacific Health Care Organization Inc | Charming Medical Ltd |
|---|---|---|---|---|
| Latest | n/a | $31.57M Ended 2025-11-30 | $6.72M Ended 2025-12-31 | $4.81M Ended 2026-03-31 |
| 1 year earlier | n/a | $31.99M Ended 2024-11-30 | $6.07M Ended 2024-12-31 | $6.22M Ended 2025-03-31 |
| 2 years earlier | n/a | $31.34M Ended 2023-11-30 | $5.63M Ended 2023-12-31 | $6.02M Ended 2024-03-31 |
| 3 years earlier | n/a | $30.34M Ended 2022-11-30 | $5.74M Ended 2022-12-31 | n/a |
| 4 years earlier | n/a | $28.88M Ended 2021-11-30 | $5.40M Ended 2021-12-31 | n/a |